Dominique P. Baeten
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications
Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.
Journal: Clinical and experimental rheumatology
Published: August 06, 2025
Dual impact of interleukin-17 A blockade on inflammatory and stromal pathways in peripheral spondyloarthritis.
Journal: Arthritis research & therapy
Published: March 16, 2025
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.
Journal: Therapeutic advances in musculoskeletal disease
Published: January 30, 2024
Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease.
Journal: The Journal of allergy and clinical immunology
Published: December 06, 2022
Contribution of Type H Blood Vessels to Pathologic Osteogenesis and Inflammation in an Experimental Spondyloarthritis Model.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 26, 2022
Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis.
Journal: International journal of molecular sciences
Published: December 13, 2021
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study.
Journal: The British journal of dermatology
Published: October 19, 2021
C-Reactive Protein Controls IL-23 Production by Human Monocytes.
Journal: International journal of molecular sciences
Published: September 29, 2021
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
Journal: JAMA dermatology
Published: August 18, 2021
Overexpression of Transmembrane TNF Drives Development of Ectopic Lymphoid Structures in the Bone Marrow and B Cell Lineage Alterations in Experimental Spondyloarthritis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 28, 2021
Paradoxical Augmentation of Experimental Spondyloarthritis by RORC Inhibition in HLA-B27 Transgenic Rats.
Journal: Frontiers in immunology
Published: April 24, 2021
Modulating Target Protein Biology Through the Re-mapping of Conformational Distributions Using Small Molecules.
Journal: Frontiers in chemistry
Published: February 15, 2021
Last Updated: 09/26/2026